[
  {
    "ts": null,
    "headline": "Chief Executives for Corporate Purpose Announces Covista Chairman and CEO Steve Beard, Cencora Inc. Former Executive Chair Steven H. Collis, and Ann Fairchild, interim President and CEO of Siemens USA Joining Board of Directors",
    "summary": "NEW YORK CITY, NY / ACCESS Newswire / February 9, 2026 / Chief Executives for Corporate Purpose® (CECP) announced today that three distinguished executives will join the organization's Board of Directors: Steve Beard, Chairman and CEO of Covista, ...",
    "url": "https://finnhub.io/api/news?id=b967597332843ba000927d6dd32cd8f70188257c886eb7f1d84149addeee4ff9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770651000,
      "headline": "Chief Executives for Corporate Purpose Announces Covista Chairman and CEO Steve Beard, Cencora Inc. Former Executive Chair Steven H. Collis, and Ann Fairchild, interim President and CEO of Siemens USA Joining Board of Directors",
      "id": 138515876,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "NEW YORK CITY, NY / ACCESS Newswire / February 9, 2026 / Chief Executives for Corporate Purpose® (CECP) announced today that three distinguished executives will join the organization's Board of Directors: Steve Beard, Chairman and CEO of Covista, ...",
      "url": "https://finnhub.io/api/news?id=b967597332843ba000927d6dd32cd8f70188257c886eb7f1d84149addeee4ff9"
    }
  },
  {
    "ts": null,
    "headline": "Morgan Stanley Raises Cardinal Health, Inc. (CAH) Price Target After Strong Q2",
    "summary": "Cardinal Health, Inc. (NYSE:CAH) is included among 12 Unstoppable Dividend Stocks to Buy According to Analysts. Morgan Stanley boosted its price recommendation on Cardinal Health, Inc. (NYSE:CAH) to $255 from $245 on February 6. The firm kept an Overweight rating on the stock. In a research note, the analyst said the firm updated its view […]",
    "url": "https://finnhub.io/api/news?id=5453358f41b49c1816e63fa1b28f03b42e8bd8760a7cdf582b4b0e066688370f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770642304,
      "headline": "Morgan Stanley Raises Cardinal Health, Inc. (CAH) Price Target After Strong Q2",
      "id": 138415898,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "Cardinal Health, Inc. (NYSE:CAH) is included among 12 Unstoppable Dividend Stocks to Buy According to Analysts. Morgan Stanley boosted its price recommendation on Cardinal Health, Inc. (NYSE:CAH) to $255 from $245 on February 6. The firm kept an Overweight rating on the stock. In a research note, the analyst said the firm updated its view […]",
      "url": "https://finnhub.io/api/news?id=5453358f41b49c1816e63fa1b28f03b42e8bd8760a7cdf582b4b0e066688370f"
    }
  }
]